Cadenza Bio, Inc.

New Filing
CIK: 0002083534·Biotechnology·DELAWARE·Filed: Aug 28, 2025
Total Offering

$2,440,000

Amount Sold

$2,440,000

Investors

10

First Sale

Dec 4, 2023

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
No

Related Persons

NameRole
Carol Curtis
Related Person
Elaine Hamm
Related Person
Tom Denison
Related Person

Company

Cadenza Bio, Inc.

14504 CHAMBORD DRIVE

YUKON, OK, 73099

2176495294

SEC Filing

0002083534-25-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Cadenza Bio, Inc. Form D Filing — $2,440,000 | FilingFlow